Conversely, a polymorphism in the TLR9 gene with increased promoter activity confers a higher risk for AD and SA strains from the skin of patients with AD, but not that of normal patients, promotes an IL-1α fueled inflammation through interaction with TLR9 [[155], [156], [157]]. Here, TLR9 is linked to Alzheimer disease.